Why Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Lisa Levin
Several stocks are experiencing significant pre-market movements. Senti Biosciences, Tharimmune, TransMedics Group, GSE Systems, Unisys Corporation, Alteryx, Augmedix, Color Star Technology, CF Acquisition Corp. IV, and Tripadvisor reported gains due to various reasons such as strategic collaborations, licensing agreements, better-than-expected Q3 results, and strong FY23 revenue guidance. On the other hand, Ventyx Biosciences, Alto Ingredients, MSP Recovery, Coherus BioSciences, Ameresco, Aura Biosciences, Clover Health Investments, Trevena, Tenon Medical, and NanoString Technologies reported losses due to reasons such as disappointing trial results, mixed Q3 results, and weak quarterly sales.
November 07, 2023 | 1:28 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ventyx Biosciences shares dipped 74% after the company announced disappointing efficacy results from the Phase 2 trial of VTX958 in plaque psoriasis.
The disappointing efficacy results from the Phase 2 trial of VTX958 in plaque psoriasis is a negative development for Ventyx Biosciences, which is likely to dampen investor confidence and drive the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Senti Biosciences shares surged 120.8% due to a new strategic collaboration with Celest Therapeutics for clinical development in China.
The strategic collaboration with Celest Therapeutics for clinical development in China is a positive development for Senti Biosciences, which is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100